Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in Alcohol Use Disorder
NCT07029529Phase 2Recruiting
- Sponsor
- Yale University
- Start
- May 2026
- Primary completion
- Aug 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in alcohol use disorder (AUD), sponsored by Yale University. Started May 2026; status: recruiting.
02
Drugs
apremilast
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07029529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07029529.